)
)
Madrigal Pharmaceuticals Investor Relations Material
Latest events
Q3 2024
Madrigal Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Madrigal Pharmaceuticals Inc
Access all reports
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The Company's pipeline includes product candidates that utilize its proprietary adeno-associated virus (AAV) and liposomal delivery systems. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.
Key slides for Madrigal Pharmaceuticals Inc
FDA Announcement
Madrigal Pharmaceuticals Inc
FDA Announcement
Madrigal Pharmaceuticals Inc
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
MDGL
Country
🇺🇸 United States